Advances in Living Donor Kidney Transplantation
Advances in Living Donor Kidney TransplantationKidney transplant recipients currently must take immune-suppressing medications to prevent organ rejection, which can make them vulnerable to infections and disease.
In this podcast, Joseph Leventhal, MD, PhD, explains ongoing clinical trials at Northwestern for kidney organ recipients. The research is focused on eliminating the need for anti-rejection medication by tricking the immune system into believing the new organ is part of the recipient’s body.
Joseph Leventhal, MD, PhD, is a transplant surgeon on the medical staff at Northwestern Memorial and associate professor of Surgery at Northwestern University Feinberg School of Medicine. He is also Director of Kidney and Pancreas Transplantation at Feinberg.